Recruiting at 1 site Phase 2 Aphasia

Clinical trial for Aphasia

Official title Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia

ClinicalTrials.gov ID: NCT06842745

What this study is testing

What it's testing
This study aims to find out if combining brain stimulation with speech therapy improves talking and understanding. It also looks for signs that show who might benefit most from this treatment.
Who it's for
The study is looking for adults who have had a stroke and now have mild difficulty with speech and language.
What's involved
Participants will have an MRI scan and then receive 10 days of brain stimulation and speech therapy. Some people will get real stimulation, while others will get a fake version to compare results.
Time commitment
The main treatment lasts one week, with follow-up visits two and four months later.
  • Phase 2: a mid-size study of how well it works

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 40 to 85

You may be able to join if

  • Left Hemisphere stroke
  • Stroke occurred more than 6 months ago
  • Mild Aphasia (WAB AQ score \> 85)
  • Proficient in English

You likely can't join if

  • Ongoing substance or alcohol abuse
  • Other neurological disorders, beside stroke (i.e. dementia, traumatic brain injury, multiple sclerosis)
  • Active psychiatric disorders (i.e. bipolar disorder, schizophrenia)
  • Pacemaker or cardiac defibrillator
  • Diagnosis of tinnitus
  • Epilepsy, or seizure in the past 6 months

The study team makes the final eligibility decision.

Where it is enrolling

  • Philadelphia, Pennsylvania, United States

Compensation & support

A stipend or payment for your time may be offered.

No amount is published here because ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team, so confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 40 years to 85 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.